BOX Balance Sheet - Becton Dickinson and Co

Watchlist Manager

Watchlist

Price: 202.6 EUR -1.65% Market Closed

Market Cap: €55.2B

B	Becton Dickinson and Co XMUN:BOX	US
	F.C.C. Co Ltd OTC:FCVFF	JP
P	Pro Medicus Ltd DUS:PMC	AU
M	Mueller Water Products Inc SWB:JT5	US
F	FRoSTA AG SWB:NLM	DE
C	Capri Holdings Ltd F:MKO	UK
	Daito Trust Construction Co Ltd F:4D7	JP
C	Coloplast A/S F:CBH	DK

Financial profile · Q3 FY2026

A diversified MedTech platform with durable cash generation and recurring restructuring noise

BDX has historically combined steady medical-device revenue growth with operating leverage and substantial operating cash generation. The model requires ongoing manufacturing investment, while acquisition, restructuring, remediation, and separation-related items make GAAP earnings more variable than cash flow.

What is developing

The latest supplied quarter shows softer revenue, operating margin, and common earnings, but the comparison is affected by the 2026 portfolio separation and trailing cash generation remains positive. That points to a meaningful reporting and earnings-quality development rather than a demonstrated break in the underlying cash model.

What matters next

Whether post-separation comparable revenue and operating margin stabilize while TTM operating cash flow remains positive.

Metric	FY2016 Sep 2016	FY2017 Sep 2017	FY2018 Sep 2018	FY2019 Sep 2019	FY2020 Sep 2020	FY2021 Sep 2021	FY2022 Sep 2022	FY2023 Sep 2023	FY2024 Sep 2024	FY2025 Sep 2025
Cash & Cash Equivalents	1.5B	14.2B	1.1B	536m	2.8B	2.3B	1B	1.4B	1.7B	641m
Cash Equivalents	1.5B	14.2B	1.1B	536m	2.8B	2.3B	1B	1.4B	1.7B	641m
Short-Term Investments	27m	21m	17m	30m	20m	12m	8m	8m	445m	8m
Total Receivables	1.6B	1.7B	2.3B	2.3B	2.4B	2.5B	2.2B	2.5B	3B	3B
Accounts Receivables	1.6B	1.7B	2.3B	2.3B	2.4B	2.5B	2.2B	2.5B	3B	3B
Other Receivables	0	0	0	0	0	0	0	0	0	0
Inventory	1.7B	1.8B	2.5B	2.6B	2.7B	2.9B	3.2B	3.3B	3.8B	3.9B
Other Current Assets	1.5B	871m	1.5B	1.2B	983m	1.2B	1.7B	1.4B	1.4B	1.7B
Total Current Assets	6.4B	18.6B	7.4B	6.7B	9B	8.8B	8.1B	8.7B	10.5B	9.3B
PP&E Net	3.9B	4.6B	5.4B	5.7B	5.9B	6.4B	6B	6.6B	7.7B	7.9B
PP&E Gross	3.9B	4.6B	5.4B	5.7B	5.9B	6.4B	6B	6.6B	7.7B	7.9B
Accumulated Depreciation	(4.5B)	(4.8B)	(5.1B)	(5.5B)	(6B)	(6.5B)	(6.4B)	(7B)	(7.6B)	(8.1B)
Intangible Assets	6.4B	5.9B	16.4B	15B	13.8B	12.8B	12.3B	10.9B	10.9B	9.4B
Goodwill	7.4B	7.6B	23.6B	23.4B	23.6B	23.9B	24.6B	24.5B	26.5B	26.6B
Other Long-Term Assets	1.5B	1B	1.1B	1.1B	1.7B	2B	1.9B	2.1B	1.7B	2.2B
Other Assets	7.4B	7.6B	23.6B	23.4B	23.6B	23.9B	24.6B	24.5B	26.5B	26.6B
Total Assets	25.6B	37.7B	53.9B	51.8B	54B	53.9B	52.9B	52.8B	57.3B	55.3B
Accounts Payable	3.2B	797m	1.1B	1.1B	1.4B	1.8B	1.7B	1.6B	1.9B	2B
Accrued Liabilities	—	2.2B	3.2B	3.1B	3.6B	4.2B	3.8B	3.7B	4.7B	4.4B
Short-Term Debt	201m	3m	10m	10m	5m	500m	230m	0	400m	855m
Current Portion of Long-Term Debt	800m	200m	2.6B	1.3B	702m	0	1.9B	1.1B	1.8B	705m
Other Current Liabilities	220m	183m	344m	140m	143m	176m	157m	140m	168m	330m
Total Current Liabilities	4.4B	3.3B	7.2B	5.7B	5.8B	6.6B	7.8B	6.6B	9B	8.3B
Long-Term Debt	10.6B	18.7B	18.9B	18.1B	17.2B	17.1B	13.9B	14.7B	17.9B	17.6B
Deferred Income Tax	1.7B	1.6B	5.7B	5.7B	5.8B	5.2B	5.1B	2.5B	2.1B	1.8B
Other Liabilities	1.3B	1.2B	1.1B	1.3B	1.4B	1.2B	903m	3.2B	2.4B	2.2B
Total Liabilities	18B	24.8B	32.9B	30.7B	30.2B	30.2B	27.7B	27B	31.4B	29.9B
Common Stock	333m	349m	349m	349m	367m	367m	367m	371m	371m	371m
Retained Earnings	12.7B	13.1B	12.6B	12.9B	12.8B	13.8B	15.2B	15.5B	16.1B	16.6B
Additional Paid In Capital	4.7B	9.6B	16.2B	16.3B	19.3B	19.3B	19.6B	19.7B	19.9B	20.1B
Unrealized Security Profit/Loss	—	—	—	—	—	—	—	—	(1m)	0
Treasury Stock	(8.2B)	(8.4B)	(6.2B)	(6.2B)	(6.1B)	(7.7B)	(8.3B)	(8.3B)	(8.8B)	(9.8B)
Other Equity	(1.9B)	(1.7B)	(1.9B)	(2.3B)	(2.5B)	(2.1B)	(1.5B)	(1.5B)	(1.7B)	(1.9B)
Total Equity	7.6B	12.9B	21B	21.1B	23.8B	23.7B	25.3B	25.8B	25.9B	25.4B
Total Liabilities & Equity	25.6B	37.7B	53.9B	51.8B	54B	53.9B	52.9B	52.8B	57.3B	55.3B
Common Shares Outstanding	213.3m	227.9m	268.2m	270.4m	290m	284.5m	283.4m	290.4m	289.1m	285.4m